Bienenstock, J., et al. (2013). Fucosylated but not sialylated milk oligosaccharides diminish colon motor contractions. PLOS ONE, 8.
Bode, L. (2012). Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology, 22: 1147-62.
Bode, L., et al. (2012). Structure-function relationship of human milk oligosaccharides. Adv. Nutr., 3: 383-91.
Bode, L. (2006). Recent advances on structure, metabolism, and function of human milk oligosaccharides. J. Nutr., 136: 2127-2130.
Boehm, G., et al. (2007). Oligosaccharides from milk. J. Nutr., 137:847-9.
Brand Miller, J. (1999). Human milk oligosaccharides: 130 reasons to breast-feed. British J. Nutrition, 82: 333-35.
Bruggencate, S., et al. (2014). Functional role and mechanisms of sialyllactose and other sialylated milk oligosaccharides.. Nutrition Reviews: Epub.
Castanys-Munoz, E., et al. (2013). 2’-fucosyllactose: an abundant, genetically determined soluble glycan present in human milk. Nutrition Reviews: Epub.
Coppa, G. V., et al. (1999). Oligosaccharides in human milk during different phases of lactation. Acta. Paediatr. Suppl., 88: 89-94.
Hennet, T., et al. (2014). Decoding breast milk oligosaccharides. Swiss Med. Wkly., 19.
Holmlund, U., et al. (2010). Maternal country of origin, breast milk characteristics and potential influences on immunity in offspring. Clinical and Experimental Immunology, 162: 500-9.
Jantscher-Krenn, E., et al. (2012). Human milk oligosaccharides and their potential benefits for the breast-fed neonate. Minerva Pediatr., 64: 83-99.
Kunz, C. (2012). Historical aspects of human milk oligosaccharides. Adv. Nutr. 3: 430-9.
Kunz, C., et al. (2006). Health promoting aspects of milk oligosaccharides. International Dairy Journal, 16: 1341-1346.
Marx, C., et al. (2014). Human milk oligosaccharide composition differs between donor milk and mother’s own milk in NICU. Journal of Human Lactation, 30: 54-61.
Morrow, A. L., et al. (2011). Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants. The Journal of Pediatrics, 158: 745-51.
Nakhla, T., et al. (1999). Neutral oligosaccharide content of preterm human milk. British Journal of Nutrition, 82: 361-7.
Newburg, D. S. (2013). Glycobiology of human milk. Biochemistry, 78: 771-85.
Obermeier, S., et al. (1999). Secretion of 13C-labelled oligosaccharides into human milk and infant’s urine after an oral [13C]galactose load. Isotopes Environ Health Stud., 35: 119-25.
Oriquat, G. A. (2011). Soluble CD14, sialic acid and L-Fucose in breast milk and their role in increasing the immunity of breast-fed infants. American Journal of Biochemistry and Biotechnology, 7: 21-28.
Rudloff, S., et al. (2012). Milk oligosaccharides and metabolism in infants. Adv. Nutr., 3: 398-405.
Sabharwal, H., et al. (1991). Sialylated oligosaccharides in human milk and feces of preterm, full-term, and weaning infants. Journal of Pediatric Gastroenterology and Nutrition, 12: 480-84.
Schauer, R. (2004). Sialic acids: fascinating sugars in higher animals and man. Zoology, 107: 49-64.
Thurl, S., et al. (2010). Variation of human milk oligosaccharides in relation to milk groups and lactational periods. British J. Nutr., 104: 1261-71.
Urashima, T., et al. (2012). The predominance of type I oligosaccharides is a feature specific to human breast milk. Adv. Nutr., 3: 473-82.
Urashima, T., et al. (2012). Evolution of milk oligosaccharides and lactose: a hypothesis. Animal., 6: 369-74.
Vos, A. P. (2007). Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr. Allergy Immunol., 18: 304-12.